• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - MAPLE GROVE ELUVIA¿ DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - MAPLE GROVE ELUVIA¿ DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number H74939295701510
Device Problems Fracture (1260); Stretched (1601); Activation, Positioning or Separation Problem (2906)
Patient Problems Thrombosis (2100); Device Embedded In Tissue or Plaque (3165)
Event Date 01/18/2017
Event Type  Injury  
Manufacturer Narrative
Initial reporter phone: (b)(6).(b)(4).
 
Event Description
It was reported that deployment difficulties, stent fracture and stent damage occurred.A 7x150,130 cm eluvia¿ drug-eluting vascular stent system was advanced to the lesion and deployment was initiated, however the stent could not be released from the delivery system.During an attempt to retrieve the stent, it elongated and broke.Approximately 4/5 of the stent was retrieved, however a portion of the stent remained in the patient.Another stent was implanted.Thrombosis with complete occlusion of the leg occurred.A lysis catheter was placed to treat the thrombus.There were no further patient complications reported and the patient was stable following the procedure.This product is only ous approved but it is similar to an approved us device.
 
Manufacturer Narrative
Age at time of event: 18 years or older.Device evaluated by mfr: returned product consisted of an eluvia self-expanding stent delivery system (sds) with a separated piece of stent.The outer shaft, middle shaft, inner shaft and the remainder of the device were checked for damage.The shaft showed a kink at the nosecone.The outer sheath showed some buckling approximately 18 to 22cm from the sheath end.The device handle was opened.There was no damage from the customer on the middle sheath; however, during the inspection and the disassembly of the device, the middle sheath suffered some kinking approximately 6.5 to 7cm from the marker band.There was also some buckling on the middle sheath approximately 101cm from the marker band.This damage was caused by the outer sheath and the middle sheath sticking together and the tensile force it took to pull the two apart caused the damage to the components.The inner liner and the proximal inner were both disassembled from the device as well and there was no customer damage done; however, during this disassembly the inner liner was kinked.When received it was noticed that the stent was in the device but it was partially deployed sticking out the distal end.When the device was disassembled during analysis the stent was removed from the device.It was also noticed that a partial piece of the stent had been returned in a separate bag.The partial piece that was in the separate bag was fractured from the full stent and it was approximately 25cm in length.The partial stent piece was part of the same stent that was removed from the device.Due to the extreme damage of the stent it is impossible to determine if the complete stent was returned.Inspection of the remainder of the device, apart from the observed damage, revealed no other damage or irregularities.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The root cause is anticipated procedural complications as this event is a known physiological effect of the procedure and is noted within the dfu.(b)(4).
 
Event Description
It was further reported that the lesion was 100% stenosed, straight, and severely calcified.The lesion was predilated and the eluvia¿ device was advanced to the lesion ipsilaterally.Treatment of the thrombosis involved lysis overnight to remove the thrombus with a retrieval catheter.The patient was "well" post-procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA¿ DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - MAPLE GROVE
one scimed place
maple grove MN 55311
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6314624
MDR Text Key66916906
Report Number2134265-2017-00657
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/18/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2017
Device Model NumberH74939295701510
Device Catalogue Number39295-70151
Device Lot Number19407621
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/25/2017
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/18/2017
Initial Date FDA Received02/09/2017
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received03/09/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/12/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-